Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Corneal Mucous Plaques : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
References

Related Articles
Corneal Erosion, Recurrent

Herpes Zoster

Keratoconjunctivitis, Sicca

Sjogren Syndrome




Patient Education
Click here for patient education.



Author: Robert H Graham, MD, Senior Associate Consultant, Department of Ophthalmology, Mayo Clinic, Scottsdale, Arizona

Robert H Graham is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, and Arizona Ophthalmological Society

Coauthor(s): Roddy Frankel, MD, PhD, Consulting Staff, Department of Ophthalmology, Grayslake Eye Center

Editors: Fernando H Murillo-Lopez, MD, Senior Surgeon, Unidad Privada de Oftalmologia CEMES; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Hospital; Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri; Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Author and Editor Disclosure

Synonyms and related keywords: filamentary keratopathy, keratoconjunctivitis sicca

Background

Corneal mucous plaques are abnormal collections of a mixture of mucous, epithelial cells, and proteinaceous and lipoidal material that adhere firmly to the corneal surface. The plaques also may enmesh calcareous granules and bacteria, as well as dust particles and other foreign bodies. The mucous plaques are translucent to opaque and may vary in size and shape from multiple small islands to bizarre patterns that may involve more than one half the corneal surface.

Pathophysiology

An abnormality of the exposed surface of the superficial corneal epithelial cells, excessive mucus formation, and the presence of epithelial receptor sites for the plaque elements predispose to this condition. The normal desquamation of epithelial cells beneath the plaque is retarded, and exfoliating face cells may become incorporated in the plaque. The plaque is formed when high viscosity mucous and proteinaceous material become adherent to the deeper squamous cells of the cornea or even to the Bowman layer through the intercellular spaces, as well as through abnormally formed transcellular aperture and epithelial defects; because of its physiochemical property, the mucous plaque enmeshes the desquamated epithelial cells.

Mucous viscosity may increase as a result of dehydration, an increase in the sialomucin component, or secondary to staphylococcal infection with subsequent liberation of enzymes that lyse the mucoprotein and mucopolysaccharide components of mucous normally produced by conjunctival goblet cells.

Frequency

United States

This condition is seen primarily in patients with keratoconjunctivitis sicca.

Mortality/Morbidity

Eye pain can be present while the plaques are present.

Sex

Keratitis sicca is more common in women than in men.

Age

The incidence of keratitis sicca increases with age.



History

  • Symptoms associated with corneal plaques include blurring of vision, foreign body sensation, and marked pain.
  • Except when severe, these symptoms are often indistinguishable from those of herpes zoster, keratitis, overwear of contact lenses, and keratoconjunctivitis sicca, with or without concomitant Sjögren syndrome, rheumatoid arthritis, or other collagen vascular diseases.

Physical

  • Multiple plaques are common and are frequently bilateral. When a plaque has adhered to the cornea, it remains for a few days or weeks; recurrences may appear but seldom are in the same location. Thickened plaques with a dry surface may appear elevated well above the tear film and may even cause dellen formation.
  • Other associated findings include the following:
    • Chronic blepharoconjunctivitis
    • Blepharospasm
    • Ciliary or conjunctival injection
    • Conjunctival mucoid discharge
    • Conjunctival filaments
    • Filamentary keratitis
    • Decreased corneal sensation
    • Mild iritis with or without keratic precipitates
    • Corneal epithelial and stromal edema in association with herpes zoster keratitis
  • Corneal epithelial defects

Causes

  • Corneal mucous plaques occur primarily in patients with keratoconjunctivitis sicca, but they also may be seen with herpes zoster, vernal keratoconjunctivitis and other forms of keratitis, and after local radiation exposure.
  • Delayed plaques and pseudodendrites associated with herpes zoster also may be infectious because they are positive for zoster DNA by polymerase chain reaction.



Corneal Erosion, Recurrent
Herpes Zoster
Keratoconjunctivitis, Sicca
Sjogren Syndrome

Other Problems to be Considered

Keratitis
Overwear of contact lenses
Rheumatoid arthritis
Other collagen vascular diseases



Other Tests

  • Fluorescein, rose bengal, or lissamine green staining, along with Schirmer testing, can be helpful in making the diagnosis of dry eye syndrome.



Medical Care

The use and concentration of topic mucolytic agents, such as acetylcysteine, should be individualized to the severity of the disease and symptoms. Topically applied 10-20% acetylcysteine drops 1-4 times daily can rapidly loosen the adherent plaque by dissolving the mucoid component. Continued therapy may result in plaque recurrence. Plaques may still occur in patients receiving acetylcysteine treatment, but the mucus adherence is usually weaker and the plaques are shorter-lived than those formed in the absence of mucolytic therapy.

Mucous plaques causing more severe symptoms may be mechanically retrieved by scraping with a spatula, pulling with forceps, or debriding with a cotton swab or Weck-cel sponge. A bandage soft contact lens applied to the cornea may both enhance patient comfort and prevent recurrence of plaques. However, due to frequently associated keratoconjunctivitis sicca, tear film abnormalities, and contact lens deposit formation, the bandage contact lens may need frequent replacement or cleaning. Plaques also may recur if the bandage contact lens is discontinued.

Staphylococcal blepharitis may predispose patients to corneal mucous plaque formation. Therefore, when appropriate, treatments should include adequate control of associated local microbial infection and colonization.

  • Artificial tear preparations may be indicated for the treatment of dry eye. In the presence of filamentary keratitis and the formation of excessive mucous, hypotonic artificial tear substitutes (rather than the viscous type of tear substitutes) may be combined with acetylcysteine. The use of preservative-free tear substitutes or lubricants is preferable due to the epithelial toxicity exhibited by many ophthalmic preservatives such as benzalkonium chloride, chlorobutanol, and thimerosal.
  • Delayed plaques and pseudodendrites associated with herpes zoster may be responsive to certain antiviral therapy.
  • Excimer laser phototherapeutic keratectomy has been demonstrated as a useful adjunct to the treatment of shield-shaped keratoconjunctivitis.

Consultations

In patients with Sjögren syndrome, a rheumatology consult may be helpful.



The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Drug Category: Topical collagenase inhibitors

Used to inhibit lytic effect of collagenase.

Drug NameN-acetylcysteine (Mucomyst 20%)
DescriptionAction is somewhat unclear. Mucomyst 20% is diluted to a 10% solution with artificial tears. Use of this medication dissolves mucous plaques.
Adult Dose1-2 gtt in affected eye(s) qd/qid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyA - Safe in pregnancy
PrecautionsAcetylcysteine sensitization may rarely occur; dilutions should be freshly prepared and used within 1 h; keep refrigerated



Complications

  • Corneal plaques may cause eye pain and blurred vision during their presence. They also can be associated with epithelial defects.

Prognosis

  • They generally only last a few days to a few weeks; however, they can reoccur but usually not in the same location.



Medical/Legal Pitfalls

  • Accurate diagnosis will allow patient explanation for cause of discomfort and decreased vision.



  • Autrata R, Rehurek J, Holousova M. [Phototherapeutic keratectomy in the treatment of corneal surface disorders in children]. Cesk Slov Oftalmol. Apr 2002;58(2):105-11. [Medline].
  • Cameron JA, Antonios SR, Badr IA. Excimer laser phototherapeutic keratectomy for shield ulcers and corneal plaques in vernal keratoconjunctivitis. J Refract Surg. Jan-Feb 1995;11(1):31-5. [Medline].
  • Doughty MJ. Impact of brief exposure to balanced salts solution or cetylpyridinium chloride on the surface appearance of the rabbit corneal epithelium--a scanning electron microscopy study. Curr Eye Res. Jun 2003;26(6):335-46. [Medline].
  • Fraunfelder FT, Wright P, Tripathi RC. Corneal mucus plaques. Am J Ophthalmol. Feb 1977;83(2):191-7. [Medline].
  • Golubovic S, Parunovic A. Vernal conjunctivitis--a cause of corneal mucoid plaques. Fortschr Ophthalmol. 1986;83(3):272-4. [Medline].
  • Liesegang TJ. Corneal complications from herpes zoster ophthalmicus. Ophthalmology. Mar 1985;92(3):316-24. [Medline].
  • Marsh RJ, Fraunfelder FT, McGill JI. Herpetic corneal epithelial disease. Arch Ophthalmol. Nov 1976;94(11):1899-1902. [Medline].
  • Marsh RJ, Cooper M. Ophthalmic zoster: mucous plaque keratitis. Br J Ophthalmol. Oct 1987;71(10):725-8. [Medline].
  • Pavan-Langston D, Yamamoto S, Dunkel EC. Delayed herpes zoster pseudodendrites. Polymerase chain reaction detection of viral DNA and a role for antiviral therapy. Arch Ophthalmol. Nov 1995;113(11):1381-5. [Medline].
  • Shaw EL, Gasset AR. Management of an unusual case of keratitis mucosa with hydrophilic contact lenses and N-acetylcysteine. Ann Ophthalmol. Oct 1974;6(10):1054-6. [Medline].
  • Tripathi BJ, Tripathi RC, Kolli SP. Cytotoxicity of ophthalmic preservatives on human corneal epithelium. Lens Eye Tox Res. 1993;9:361-74.
  • Tripathi RC, Tripathi BJ, Silverman RA, Rao GN. Contact lens deposits and spoilage: identification and management. Int Ophthalmol Clin. Spring 1991;31(2):91-120. [Medline].

Corneal Mucous Plaques excerpt

Article Last Updated: Jun 26, 2006